Published in Proc Natl Acad Sci U S A on April 01, 1983
Inhibition of Ehrlichia risticii infection in murine peritoneal macrophages by gamma interferon, a calcium ionophore, and concanavalin A. Infect Immun (1991) 1.14
Macrophage cell lines P388D1 and IC-21 stimulated with gamma interferon fail to inhibit the intracellular growth of Histoplasma capsulatum. Infect Immun (1989) 0.97
Simultaneous expression of Ia and cytocidal activity by macrophages, and the consequences for antigen presentation. Immunology (1987) 0.93
Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity. J Exp Med (1979) 5.38
Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages. J Exp Med (1980) 5.24
Macrophage Ia antigens. I. macrophage populations differ in their expression of Ia antigens. J Immunol (1978) 4.04
A subpopulation of adherent accessory cells bearing both I-A and I-E or C subregion antigens is required for antigen-specific murine T lymphocyte proliferation. J Immunol (1978) 2.54
Demonstration of a soluble mediator that induces exudates rich in Ia-positive macrophages. J Exp Med (1980) 2.38
Regulation of murine macrophage Ia-antigen expression by products of activated spleen cells. J Exp Med (1980) 2.19
The murine Kupffer cell. I. Characterization of the cell serving accessory function in antigen-specific T cell proliferation. J Immunol (1979) 2.15
Induction of cytocidal macrophages after in vitro interactions between Listeria-immune T cells and macrophages--role of H-2. J Immunol (1979) 2.00
The expression of Ia antigens on immunocompetent cells in the guinea pig. II. Ia antigens on macrophages. J Immunol (1977) 1.96
IA antigens and antigen-presenting function of thymic macrophages. J Immunol (1980) 1.87
Regulation of macrophage populations. V. Evaluation of the control of macrophage Ia expression in vitro. J Immunol (1982) 1.60
Evidence for the identity of murine gamma interferon and macrophage activating factor. J Interferon Res (1982) 1.48
Regulation of macrophage populations. III. The immunologic induction of exudates rich in Ia-bearing macrophages is a radiosensitive process. J Immunol (1982) 1.16
Relation between bactericidal and phagocytic activities of peritoneal macrophages induced by irritants. J Reticuloendothel Soc (1980) 0.96
A convenient and sensitive cytotoxicity assay for macrophage activating factor. J Immunol Methods (1982) 0.92
Characterization of Ia-positive peritoneal exudate cells which augment concanavalin A response of T cells. Cell Immunol (1979) 0.89
Surface antigens of the murine cytostatic peritoneal macrophage. Immunology (1980) 0.84
Binding of bacillus Calmette-Guérin-activated macrophages to tumor targets. Selective inhibition by membrane preparations from homologous and heterologous neoplastic cells. J Exp Med (1981) 0.80
Differential effects of prostaglandins on the antitumor activity of normal and BCG-activated macrophages. Cell Immunol (1981) 0.78
Interferon-mediated protein kinase and low-molecular-weight inhibitor of protein synthesis. Nature (1976) 3.58
A new family of plant antifungal proteins. Mol Plant Microbe Interact (1992) 3.33
Mechanism of antibody diversity: germ line basis for variability. Science (1970) 3.05
Antigenic competition: cellular or humoral. Science (1967) 2.95
Dimethyl sulfoxide prevents DNA nicking mediated by ionizing radiation or iron/hydrogen peroxide-generated hydroxyl radical. Proc Natl Acad Sci U S A (1981) 2.13
Use of low concentrations of actinomycin D in the study of RNA synthesis in Ehrlich ascites cells. J Mol Biol (1966) 2.11
Evidence that approximately eighty per cent of the soluble proteins from Ehrlich ascites cells are Nalpha-acetylated. J Biol Chem (1976) 1.96
Suppression of in vitro cytotoxic response by macrophages due to induced arginase. J Exp Med (1977) 1.92
Regulation of the immune response: production of a soluble suppressor by immune spleen cells in vitro. J Immunol (1975) 1.85
Effect of organ culture on the survival of thyroid allografts in mice. Transplantation (1976) 1.83
Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science (1976) 1.80
Isolation and partial characterization of two antifungal proteins from barley. Biochim Biophys Acta (1986) 1.70
Coordinate production by a T cell hybridoma of gamma interferon and three other lymphokine activities: multiple activities of a single lymphokine? J Immunol (1983) 1.67
An extracellular nuclease from Serratia marcescens. I. Purification and some properties of the enzyme. J Biol Chem (1969) 1.62
Encephalomyocarditis virus RNA. III. Presence of a genome-associated protein. J Virol (1978) 1.59
Melanin as a potential cryptococcal defence against microbicidal proteins. Med Mycol (1999) 1.48
Evidence for the identity of murine gamma interferon and macrophage activating factor. J Interferon Res (1982) 1.48
Isolation and enumeration of peripheral blood monocytes. J Immunol (1977) 1.48
T cell rosette formation in primates, pigs, and guinea pigs. The influence of immunosuppresive agents. J Allergy Clin Immunol (1974) 1.45
The antibody response: a model based on antagonistic actions of antigen. J Theor Biol (1963) 1.43
Activation of cytotoxic T cells by nonstimulating tumor cells and spleen cell factor(s). Proc Natl Acad Sci U S A (1977) 1.38
The enhancing effect of bone marrow cells on the immune response of irradiated mice reconstituted with spleen cells from normal and immunized donors. J Immunol (1968) 1.35
2-5A accumulates to high levels in interferon-treated, vaccinia virus-infected cells in the absence of any inhibition of virus replication. J Virol (1984) 1.29
Mechanism of Mengo virus-induced cell injury in L cells: use of inhibitors of protein synthesis to dissociate virus-specific events. J Virol (1972) 1.29
Cell interaction in antibody synthesis. J Allergy (1969) 1.28
An extracellular nuclease from Serratia marcescens. II. Specificity of the enzyme. J Biol Chem (1969) 1.27
Encephalomyocarditis virus RNA: variations in polyadenylic acid content and biological activity. J Virol (1976) 1.24
Immunological induction of T lymphocytes: role of antigen and the lymphocyte costimulator. Blood Cells (1978) 1.23
Studies on RNA synthesis in Ehrlich ascites cells extraction and properties of labeled RNA. Biochim Biophys Acta (1965) 1.13
Use of benzoylated cellulose columns for the isolation of poly(adenylic acid) containing RNA and other polynucleotides with little secondary structure. Biochemistry (1974) 1.11
The specific substance from Pneumococcus type 34 (41). The phosphodiester linkages. Biochem J (1968) 1.09
Purification and properties of a translation inhibitor from wheat germ. Biochemistry (1979) 1.09
Human MDR 1 protein overexpression delays the apoptotic cascade in Chinese hamster ovary fibroblasts. Biochemistry (1997) 1.08
Encephalomyocarditis virus RNA. II. Polyadenylic acid requirement for efficient translation. J Virol (1977) 1.07
Simian virus 40-infected, interferon-treated cells contain 2',5'-oligoadenylates which do not activate cleavage of RNA. J Biol Chem (1984) 1.04
The failure of a major histocompatibility antigen to stimulate a thyroid allograft reaction after culture in oxygen. J Exp Med (1983) 1.02
Effect of oxygen pressure during culture on survival of mouse thyroid allografts. Science (1978) 1.02
Cell interaction in antibody synthesis. Adv Immunol (1970) 1.01
Interferon-induced inhibition of protein synthesis in L-cell extracts: an ATP-dependent step in the activation of an inhibitor by double-stranded RNA. Proc Natl Acad Sci U S A (1976) 1.01
Stability of biodegradable radioactive rhenium (Re-186 and Re-188) microspheres after neutron-activation. Appl Radiat Isot (2001) 0.97
The reaction of immunoglobulin-coated bentonite and radioiodinated antigen as a basis for antibody detection and antigen binding. J Immunol (1969) 0.97
An ATP-dependent inhibition of protein synthesis in ascites cell extracts by wheat germ protein. Biochim Biophys Acta (1977) 0.94
Characterization and poly(adenylic acid) content of Ehrlich ascites cell ribonucleic acids fractionated on unmodified cellulose columns. Biochemistry (1973) 0.93
Decreased pulmonary vasoreactivity in an animal model of chronic Pseudomonas pneumonia. Am Rev Respir Dis (1990) 0.93
A convenient and sensitive cytotoxicity assay for macrophage activating factor. J Immunol Methods (1982) 0.92
An animal model of antibody binding in cutaneous lupus. Arthritis Rheum (1986) 0.92
Plant proteins that inactivate foreign ribosomes. Biosci Rep (1986) 0.91
Theory of allogeneic reactivity and its relevance to transplantation biology. Transplant Proc (1976) 0.90
Thymocytes, macrophages, and erythrocytes. J Allergy Clin Immunol (1974) 0.89
Synthesis of Maus-Elberfeld viral RNA in ascites tumor cells. J Mol Biol (1966) 0.88
Novel 2',5'-oligoadenylates synthesized in interferon-treated, vaccinia virus-infected cells. J Virol (1985) 0.87
The protein concentration of crude cell and tissue extracts as estimated by the method of dye binding: comparison with the Lowry method. Anal Biochem (1979) 0.87
Factor requirements for the tritin inactivation of animal cell ribosomes. Biochim Biophys Acta (1981) 0.87
Effects of dietary potassium upon growth, serum electrolytes and intrarumen environment of finishing beef steers. J Anim Sci (1969) 0.86
Evidence for a role of tert-butyl hydroxylation in the induction of pneumotoxicity in mice by butylated hydroxytoluene. Toxicol Appl Pharmacol (1989) 0.86
Enhancement of the primary cytotoxic response to membrane by a lymphokine costimulator. Proc Natl Acad Sci U S A (1979) 0.86
Rejection of stable cultured allografts by active or passive (adoptive) immunization. Proc Natl Acad Sci U S A (1982) 0.86
Assay of (2'-5')-oligo(A) synthesized in vitro and the analysis of naturally occurring (2'-5')-oligo(A) from intact cells. Methods Enzymol (1981) 0.86
A search for the optimum conditions for culturing allografts before transplantation. Clin Immunol Immunopathol (1980) 0.85
Inhibitors of animal cell-free protein synthesis from grains. Biochim Biophys Acta (1982) 0.84
The requirement for biotin and fatty acids in the cytotoxic T-cell response. Cell Immunol (1979) 0.83
Dosimetry of a W-188/Re-188 beta line source for endovascular brachytherapy. Med Phys (2000) 0.82
Synergism between minor and major histocompatibility antigens in the rejection of cultured allografts. Transplantation (1985) 0.82
Is the macrophage the stimulating cell? J Allergy Clin Immunol (1975) 0.82
Particulate forms of phenylalanyl-tRNA synthetase from Ehrlich ascites cells. Biochem Biophys Res Commun (1972) 0.82
Polyuridylic acid binding by protein from Ehrlich ascites cell ribosomes and its inhibition by aurintricarboxylic acid. Biochemistry (1971) 0.82
Limitation of reticulocyte transfer RNA in the translation of heterologous messenger RNAs. Biochemistry (1976) 0.81
Aged lymphocyte proliferation following incorporation and retention of dietary omega-3 fatty acids. Mech Ageing Dev (1994) 0.80
Inhibiton of tumor cell proliferation: second role for suppressor cells? J Immunol (1975) 0.80
A transfer RNA-dependent protein synthesizing system from Ehrlich ascites extracts. Biochim Biophys Acta (1975) 0.79
Major histocompatibility complex antigen expression of parenchymal cells of thyroid allografts is not by itself sufficient to induce rejection. Transplantation (1990) 0.79
Studies on the formation and stability of aminoacyl-tRNA synthetase complexes from Ehrlich ascites cells. Biochim Biophys Acta (1976) 0.79
Comparative immunochemical studies of primate hemoglobins. Biochem Genet (1975) 0.79
The immunologic memory of LAF mice following a single injection of sheep red cells. J Immunol (1969) 0.78
The requirement of viable thymocytes for species-specific attachment to and release from macrophages. J Immunol (1977) 0.78
Enzymic synthesis, purification, and fractionation of (2'-5')-oligoadenylic acid. Methods Enzymol (1981) 0.78
Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole. Radiat Res (1988) 0.77
T cells can be cytotoxic without making interleukin 2: a model of separate pathways of induction. Proc Natl Acad Sci U S A (1986) 0.77
A convenient synthesis of arabinosylcytosine (cytosine arabinoside). J Org Chem (1967) 0.77
Purification and properties of nuclear and cytoplasmic "deoxyribonucleic acid like" ribonucleic acid from ehrlich ascites cells. Biochemistry (1969) 0.77
Activation of T-lymphocyte helper function by brief exposure to antigen-pulsed macrophages. Proc Soc Exp Biol Med (1975) 0.77
The abrogation of thyroid allograft rejection by culture in acid medium. Transplantation (1987) 0.77
Evidence that tolerance to cultured thyroid allografts is an active immunological process. Protection of third-party grafts bearing new antigens when associated with tolerogenic antigens. Transplantation (1992) 0.77
Role of lymphokine in islet allograft rejection. Transplantation (1990) 0.77
Single point mutation or chromosomal rearrangement. Science (1965) 0.76
Basic radiobiological investigations of fast neutrons. Radiat Res (1991) 0.76
Calcium homeostasis: solving the solubility problem. J Musculoskelet Neuronal Interact (2006) 0.76
Base sequence differences between the ribosomal and "ribosomal precursor" ribonucleic acids from Ehrlich ascites cells. Biochemistry (1968) 0.76
The response of murine splenic lymphocytes to concanavalin A and to co-stimulator. J Immunol (1980) 0.76
The tolerance that develops in recipients of cultured allografts is an active process that affects both the activation and effector function of cytotoxic T cells. Prog Clin Biol Res (1986) 0.76
Melatonin: immune modulation of spleen cells in young, middle-aged and senescent mice. Mech Ageing Dev (1998) 0.76
Immunosuppression by a mouse tumor resembles antigenic competition. Proc Natl Acad Sci U S A (1979) 0.75
The effects of different conditions of organ culture on the survival of the mouse pancreas. Diabetes (1979) 0.75
Status report of the Cleveland Clinic Foundation National Aeronautics and Space Administration Neutron Therapy Center. Strahlentherapie Sonderb (1981) 0.75
Role of gamma-interferon in islet allograft rejection: class I MHC antigen induction. Transplant Proc (1989) 0.75